P eripartum cardiomyopathy (PPCM) is a pregnancy-associated cardiomyopathy of unknown cause resulting in considerable morbidity and mortality in young, otherwise healthy women. The natural history of PPCM seems to be variable although the rarity of this disease and the inconsistent diagnostic criteria that have been used in previous case series and research studies make it difficult to accurately describe the range of disease progression. Retrospective studies of patients with PPCM in the United States have shown that mortality is as high as 18%, [1] [2] [3] [4] [5] [6] and left ventricular (LV) ejection fraction (LVEF) returns to normal at 6 months to 1 year in only 40% to 62% of patients. 3, [6] [7] [8] 
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have more severe involvement, which would be associated with worse clinical outcomes. Specifically, our objective was to study whether baseline RV size and functional measures, including RV strain and tricuspid annular plane systolic excursion (TAPSE), were associated with LV recovery and clinical outcome, including death, transplant, need for LV assist device (LVAD) implantation, and persistent severe LV systolic dysfunction despite optimal medical therapy.
Methods

Study Population
The study was approved by the institutional review board at each participating center (Appendix). All participating patients provided written informed consent. Women were eligible for enrollment in this study if they met all the following study criteria: heart failure symptom onset in the last month of pregnancy or within 13 weeks after delivery, no other demonstrable cause of heart failure, and an estimated LVEF <45% within 13 weeks after delivery. One hundred women with PPCM who were aged ≥18 years and who met study criteria were enrolled at 30 centers between December 2009 and September 2012. Patients were followed up for 1 year postpartum. Details of study patients with echocardiographic and outcome data available appear in Figure 1 .
Echocardiographic Assessment
Transthoracic echocardiography was performed at enrollment and at 6 and 12 months postpartum. Patients enrolled within the first 6 weeks postpartum underwent echocardiographic assessment at 2, 6, and 12 months postpartum. Echocardiograms from all sites were reviewed and archived at a core laboratory at the University of Pittsburgh. LV end-diastolic dimension (LV EDD) and LV end-systolic dimension were measured from the parasternal long-axis view. LVEF was calculated by the biplane Simpson method with manual tracing of digital images. RV end-diastolic area (RV EDA) and RV end-systolic area (RV ESA) were measured with manual tracing of digital images from the apical 4-chamber view (Figure 2 ). RV fractional area change (RV FAC) was calculated as follows: RV FAC (%)=(RV EDA−RV ESA)/RV EDA×100. 16, 17 Tricuspid annular planar systolic excursion was measured according to the current American Society of Echocardiography guidelines. 16, 17 Speckle-Tracking Strain Assessment RV longitudinal free wall and global wall strain were assessed with speckle-tracking echocardiographic analysis. Measurements were performed offline with dedicated software (2D Cardiac Performance Analysis, TomTec Imaging Systems, Unterschleissheim, Germany). Peak longitudinal systolic strain was obtained for the basal, middle, and apical segments of the RV free wall and interventricular septum from software-generated strain curves and averaged for mean RV free wall and RV global strain values, respectively ( Figure 3 ).
Clinical and Echocardiographic Outcomes
Death, transplant, and LVAD implantation were recorded as events. LV recovery was defined as LVEF of ≥50% on the last echocardiographic assessment during the study period. Persistent LV dysfunction was defined as LVEF of ≤35% on the last echocardiographic assessment during the study period. Two combined end points of poor outcome were predefined: (1) lack of LV recovery or event and (2) persistent severe LV dysfunction or event. Last echocardiogram was defined as the 12-month postpartum echocardiogram or, if not available, the 6-month postpartum echocardiogram.
Statistical Analysis
Continuous variables were tested for normality with the KolmogorovSmirnov test and are expressed as mean±SD. The independent samples t test or the paired samples t test was used to compare variables. Categorical variables are expressed as frequencies and percentages and were compared using the χ 2 test. Receiver operating characteristic curves were constructed for each RV function parameter to determine cutoff values, sensitivities, and specificities associated with predefined outcomes. P values were obtained from receiver operating characteristic curve analysis, with P value <0.05 showing that there is evidence that the study parameter can distinguish the 2 patient groups. Kaplan-Meier survival curves were traced according to baseline RV function and compared with the log-rank test. Time to event was defined as the time from the baseline echocardiogram to the event, or to the last available echocardiogram after 6 months. RV function parameters were included in a Cox proportional hazards regression model to correct for other baseline variables. All statistical analyses were performed with MedCalc software, version 12.0.4.0 (MedCalc Software bvba, Ostend, Belgium). A 2-tailed P value of <0.05 was considered statistically significant.
Results
Echocardiograms for baseline LVEF were available for 96 of the 100 patients enrolled. In 90 of those 96 patients (94%), baseline RV functional analysis was feasible as follows: TAPSE in 90, RV FAC in 88, and RV speckle-tracking strain in 79. Among patients in whom the following parameters could be measured at baseline, 37 of 88 (42%) had dilated RV EDA (>20 cm , 33 of 88 (38%) had below-normal RV FAC (<35%), 26 of 90 (29%) had below-normal TAPSE (<17 mm), and 27 of 79 (34%) had abnormal RV longitudinal free wall strain (>−15%). 18 Baseline and last echocardiographic LV and RV results are listed in Table 1 . LV dimensions significantly decreased, At 1 year, 63 of 84 patients (75%) with ≥6 months of follow-up data available had LV recovery. Of the 21 patients remaining, 6 had events (2 died and 4 underwent LVAD implantation), and 5 had persistent severe LV dysfunction with LVEF of ≤35%. No patients required RV assist device implantation or cardiac transplant. Receiver operating characteristic curve analysis showed that lower RV FAC, larger RV EDA, larger RV ESA, and lower RV global longitudinal strain at baseline were strong predictors of the combined outcome of lack of LV recovery (LVEF <50%) or event at 1 year (P<0.001, P=0.003, P<0.001, and P<0.001, respectively; Table 2 ) and were associated with the combined end point of persistent severe LV dysfunction (LVEF ≤35%) or event (P<0.001, P=0.003, P<0.001, and P<0.001, respectively; Table 3 and Figure 4 ). Baseline TAPSE was not associated with clinical outcome.
By Kaplan-Meier analysis, patients with increased RV size or low RV function at baseline showed a high risk of poor outcome. The hazard ratio for lack of LV recovery or event was 5. 6 ). Multivariable analysis showed that after adjustment for baseline LVEF, LV EDD, and black race, RV FAC was an independent predictor of both outcomes: adjusted hazard ratio for lack of LV recovery or event was 0.95 (95% CI, 0.92-0.99; P=0.02; Table 4 ); adjusted hazard ratio for persistent LVEF of ≤35% or for event was 0.93 (95% CI, 0.87-0.99; P=0.04; Table 5 ).
At baseline, black patients had significantly lower LVEF and larger LV EDD and LV end-systolic dimension compared with patients of white or other race (P=0.047, P=0.03, and P=0.03, respectively; Table I in the Data Supplement). Although the difference was not significant, a higher percentage of black patients had RV FAC <35% (11 of 25; 44%) compared with patients of white or other race (22 of 63; 35%; P=0.58). LVEF, LV EDD, and LV end-systolic dimension significantly improved from baseline to last echocardiogram in both groups (Table II in the Data Supplement). Although patients who were self-identified as other than black showed significant improvement in all RV parameters from baseline to last echocardiogram, black patients had no significant improvement in any RV parameters during the same period.
Discussion
This is the first study to show the prognostic value of RV function by echocardiographic FAC at presentation in a large contemporary prospective series of women with PPCM. Our results showed that RV systolic dysfunction was present in one-third of patients with PPCM with various degrees of LV dysfunction at baseline and was an independent predictor of subsequent lack of recovery of LV function and clinical outcomes. After adjustment for LV dilatation and systolic 23 higher New York Heart Association class, 27 diagnosis during pregnancy, 22 delayed diagnosis, 6 lower body mass index, 23 and black African descent. 3, 6, 8, 28, 29 Previous studies have shown that RV function at diagnosis predicts outcome among adult patients with myocarditis, 13 idiopathic dilated cardiomyopathy, [9] [10] [11] [12] or newly diagnosed ischemic or nonischemic systolic heart failure. 14 The results of this study support the findings from these studies that RV systolic dysfunction in acute nonischemic dilated cardiomyopathy, including PPCM, is an independent predictor of morbidity and mortality.
The pathophysiology of PPCM is still under investigation, so the underlying mechanisms of RV dilatation and systolic 
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dysfunction in these patients are unclear. However, it seems likely that RV function is linked to LV function in at least some patients. Potential mechanisms by which LV systolic dysfunction leads to RV systolic dysfunction include involvement of the RV by the same cardiomyopathic process involving the LV, reduced interventricular septal contractility, ventricular interdependence because of septal dysfunction, decreased RV perfusion because of decreased LV systolic driving pressure, and secondary pulmonary hypertension resulting in increased RV afterload. 30 By definition, all patients with PPCM in our cohort had LV systolic dysfunction at study entry, whereas only 38% had reduced RV FAC at baseline. RV FAC remained a predictor of lack of LV recovery and the combined end point of poor outcome even after adjustment for LVEF at baseline. Therefore, although some correlation is likely between the degree of LV and RV systolic dysfunction in patients with PPCM, the severity of LV systolic dysfunction does not necessarily predict the severity of RV systolic dysfunction and risk of poor outcome.
Nearly 50% of the patients in this study had RV dilatation at baseline according to RV EDA, indexed RV EDA, RV ESA, or indexed RV ESA. Baseline RV EDA and RV ESA were predictors of lack of LV recovery and the combined end point of poor outcome in univariable analysis, but they did not remain predictors of outcome after adjustment for LVEF and LV EDD. RV longitudinal global strain, RV free wall strain, and TAPSE were not independently associated with poor outcome, but RV FAC remained an independent predictor of lack of LV recovery and the combined end point of poor outcome even after the adjustment for LVEF and LV EDD.
The reasons are not entirely clear as to why RV size alone was not an independent predictor of outcome for this cohort, but one reason may be the interplay between LV systolic dysfunction and RV size. Decreased interventricular Previous studies have shown that being of black African descent is associated with worse outcomes among patients with PPCM. This study found no significant differences in RV size or systolic function at baseline between black patients and patients of other races, but a higher percentage of black women had RV FAC <35% compared with white women (44% versus 35%). Women who were not black had significant improvement in all RV size systolic function parameters, except RV EDA, at the last echocardiogram, whereas black women appeared to have no statistically significant improvement in any RV parameters during the same period. The reason that black patients with PPCM have more severe LV and RV systolic dysfunction at presentation and less improvement in RV parameters with time is unclear, but it may be because of the fact that the number of self-identified black patients was much smaller than the number of white patients in this study. Alternatively, these differences in cardiac function at baseline and decreased improvement with time may be related to genetic differences or variations in the pathophysiologic pathways of this disease, which remain to be elucidated. The fact that RV systolic function did not significantly improve in black patients with PPCM may at least partially explain their worse outcome compared with white patients in this study, although small sample size limits our ability to confidently make this association.
This prospective study has several limitations. RV size and functional assessment at baseline could not be performed for 6 patients with unavailable complete echocardiogram. Poor image quality also precluded RV longitudinal strain analysis for 11 of the 90 patients with baseline echocardiogram. Complete clinical and echocardiographic follow-up data after 6 months were available for only 84 of the 90 patients. RV strain was assessed with vendor-independent software created for the LV, which analyzes 2-dimensional Digital Imaging and Communications in Medicine images with a limited temporal resolution (≈30 frames/s). This fact, along with small sample size, may have limited the prognostic ability of RV strain, including the lack of its independent association with LV recovery, in our study.
We acknowledge that major unfavorable clinical events, such as death, transplant, or LVAD implantation, represent a different spectrum of disease severity than persistent LV dysfunction. Because there were only 6 major events (4 LVADs and 2 deaths), these events were too few to support a separate statistical analysis of these end points. Further investigation on the impact of RV size and function on PPCM patient prognosis is thus warranted. 
Conclusion
RV FAC at presentation is a strong independent predictor of LV recovery and clinical events in patients with PPCM. This study suggests that RV FAC, which is an easily obtainable echocardiographic parameter of RV systolic function in most patients, should be assessed in patients with PPCM at diagnosis because of its important prognostic value. Further investigation into the effect of RV function on outcome among patients with PPCM is warranted.
CLINICAL PERSPECTIVE
Patients with peripartum cardiomyopathy have a variable prognosis and, to date, predicting outcomes for these patients has been challenging. Our aim was to determine whether right ventricular (RV) function at presentation impacts outcome in these patients. We assessed RV size and function at baseline, 6 months, and 12 months in patients enrolled in the Investigations of Pregnancy-Associated Cardiomyopathy (IPAC) study. Among the 84 patients in this study with >6 months of follow-up data available, 21 patients (25%) had poor outcomes: 2 patients died, 4 underwent left ventricular assist device implantation, and 15 patients had persistent left ventricular ejection fraction of <50%, among whom 5 had persistent left ventricular ejection fraction of ≤35%. We found that reduced RV fractional area change at baseline was an independent predictor of lack of left ventricular recovery and poor clinical outcome in these patients. Other RV echocardiographic parameters, including tricuspid annular plane systolic excursion and longitudinal strain, were not independent predictors of outcome. Because of the prognostic implications of baseline RV fractional area change, for patients with suspected peripartum cardiomyopathy, we recommend that RV systolic function be carefully assessed on presentation and during serial follow-up imaging.
